Records 1 - 6
| HLA-B*58: 01 carrier status of Hmong in Minnesota: first in Hmong genotyping for prevalence of this biomarker of risk for severe cutaneous adverse reactions caused by allopurinol.
Pharmacogenetics and genomics 2019 Oct .
Peng Kerui, Bjork Jonathan, Wen Ya-Feng, Roman Youssef M, Culhane-Pera Kathleen, Lo May Xia, Gertner Elie, Straka Robert
| The Interaction between Sex and Hyperlipidemia on Gout Risk Is Modulated by HLA-B Polymorphic Variants in Adult Taiwanese.
Genes 2019 Mar 10 (3): .
Hsu Tsui-Wen, Lee Pei-Shyuan, Nfor Oswald Ndi, Lee Chia-Long, Chen Pei-Hsin, Tantoh Disline Manli, Lin Long-Yau, Chou Ming-Chih, Lee Yu-Chen, Liaw Yung-
| A retrospective investigation of HLA-B*5801 in hyperuricemia patients in a Han population of China.
Pharmacogenetics and genomics 2018 Apr .
Cheng Heng, Yan Dewen, Zuo Xin, Liu Junying, Liu Wenlan, Zhang Youmi
| Febuxostat-associated drug reaction with eosinophilia and systemic symptoms (DRESS).
Journal of clinical pharmacy and therapeutics 2015 Sep .
Chou H-Y, Chen C-B, Cheng C-Y, Chen Y-A, Ng C Y, Kuo K-L, Chen W-L, Chen C
| Cost-effectiveness analysis of HLA-B5801 genotyping in the treatment of gout patients with chronic renal insufficiency in Korea.
Arthritis care & research 2015 Feb 67 (2): 280-7.
Park Dong-Jin, Kang Ji-Hyoun, Lee Jeong-Won, Lee Kyung-Eun, Wen Lihui, Kim Tae-Jong, Park Yong-Wook, Park Sung-Hwan, Lee Shin-Se
| HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.
Proceedings of the National Academy of Sciences of the United States of America 2005 Mar 102 (11): 4134-9.
Hung Shuen-Iu, Chung Wen-Hung, Liou Lieh-Bang, Chu Chen-Chung, Lin Marie, Huang Hsien-Ping, Lin Yen-Ling, Lan Joung-Liang, Yang Li-Cheng, Hong Hong-Shang, Chen Ming-Jing, Lai Ping-Chin, Wu Mai-Szu, Chu Chia-Yu, Wang Kuo-Hsien, Chen Chien-Hsiun, Fann Cathy S J, Wu Jer-Yuarn, Chen Yuan-Tso